These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 11907196)

  • 41. Prediction of in vivo rat biliary drug clearance from an in vitro hepatocyte efflux model.
    Lundquist P; Lööf J; Fagerholm U; Sjögren I; Johansson J; Briem S; Hoogstraate J; Afzelius L; Andersson TB
    Drug Metab Dispos; 2014 Mar; 42(3):459-68. PubMed ID: 24396143
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatic, intestinal, renal, and plasma hydrolysis of prodrugs in human, cynomolgus monkey, dog, and rat: implications for in vitro-in vivo extrapolation of clearance of prodrugs.
    Nishimuta H; Houston JB; Galetin A
    Drug Metab Dispos; 2014 Sep; 42(9):1522-31. PubMed ID: 24994071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches.
    Ito K; Houston JB
    Pharm Res; 2005 Jan; 22(1):103-12. PubMed ID: 15771236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regioselective glucuronidation of daidzein in liver and intestinal microsomes of humans, monkeys, rats, and mice.
    Hanioka N; Ohkawara S; Isobe T; Ochi S; Tanaka-Kagawa T; Jinno H
    Arch Toxicol; 2018 Sep; 92(9):2809-2817. PubMed ID: 30014295
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of afloqualone N-glucuronidation: species differences and identification of human UDP-glucuronosyltransferase isoform(s).
    Kaji H; Kume T
    Drug Metab Dispos; 2005 Jan; 33(1):60-7. PubMed ID: 15475412
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes.
    Riley RJ; McGinnity DF; Austin RP
    Drug Metab Dispos; 2005 Sep; 33(9):1304-11. PubMed ID: 15932954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytochrome P450 2B6 and UDP-Glucuronosyltransferase Enzyme-Mediated Clearance of Ciprofol (HSK3486) in Humans: The Role of Hepatic and Extrahepatic Metabolism.
    Zhou Y; Dong H; Fan J; Zhu M; Liu L; Wang Y; Tang P; Chen X
    Drug Metab Dispos; 2024 Jan; 52(2):106-117. PubMed ID: 38071562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differences in the pharmacokinetics of peroxisome proliferator-activated receptor agonists in genetically obese Zucker and sprague-dawley rats: implications of decreased glucuronidation in obese Zucker rats.
    Kim MS; Wang S; Shen Z; Kochansky CJ; Strauss JR; Franklin RB; Vincent SH
    Drug Metab Dispos; 2004 Sep; 32(9):909-14. PubMed ID: 15319330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of inhibition potentials of drugs against zidovudine glucuronidation in rat hepatocytes and liver microsomes.
    Mano Y; Usui T; Kamimura H
    Drug Metab Dispos; 2007 Apr; 35(4):602-6. PubMed ID: 17267620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. S-equol glucuronidation in liver and intestinal microsomes of humans, monkeys, dogs, rats, and mice.
    Isobe T; Ohkawara S; Ochi S; Tanaka-Kagawa T; Hanioka N
    Food Chem Toxicol; 2019 Sep; 131():110542. PubMed ID: 31163218
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro glucuronidation of propofol in microsomal fractions from human liver, intestine and kidney: tissue distribution and physiological role of UGT1A9.
    Mukai M; Tanaka S; Yamamoto K; Murata M; Okada K; Isobe T; Shigeyama M; Hichiya H; Hanioka N
    Pharmazie; 2014 Nov; 69(11):829-32. PubMed ID: 25985579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Utility of hepatocytes in predicting drug metabolism: comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro.
    Naritomi Y; Terashita S; Kagayama A; Sugiyama Y
    Drug Metab Dispos; 2003 May; 31(5):580-8. PubMed ID: 12695346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of pharmaceutical excipients as cosolvents in 4-methyl umbelliferone glucuronidation in human liver microsomes: applications for compounds with low solubility.
    Argikar UA; Liang G; Bushee JL; Hosagrahara VP; Lee W
    Drug Metab Pharmacokinet; 2011; 26(1):102-6. PubMed ID: 21084760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction of metabolic clearance using cryopreserved human hepatocytes: kinetic characteristics for five benzodiazepines.
    Hallifax D; Rawden HC; Hakooz N; Houston JB
    Drug Metab Dispos; 2005 Dec; 33(12):1852-8. PubMed ID: 16174807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization.
    Prueksaritanont T; Subramanian R; Fang X; Ma B; Qiu Y; Lin JH; Pearson PG; Baillie TA
    Drug Metab Dispos; 2002 May; 30(5):505-12. PubMed ID: 11950779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clearance Prediction of Targeted Covalent Inhibitors by In Vitro-In Vivo Extrapolation of Hepatic and Extrahepatic Clearance Mechanisms.
    Leung L; Yang X; Strelevitz TJ; Montgomery J; Brown MF; Zientek MA; Banfield C; Gilbert AM; Thorarensen A; Dowty ME
    Drug Metab Dispos; 2017 Jan; 45(1):1-7. PubMed ID: 27784718
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of ultra high-performance liquid chromatography tandem mass spectrometry to investigate the regioselective glucuronidation of icaritin in vitro.
    Rong Y; Meng Z; Li J; Zhu X; Gan H; Gu R; Wu Z; Sun W; Liu T; Zheng Y; Jin M; Peng J; Wang X; Dou G
    J Pharm Biomed Anal; 2018 May; 154():444-453. PubMed ID: 29587224
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glucuronidation of propofol in microsomal fractions from various tissues and species including humans: effect of different drugs.
    Le Guellec C; Lacarelle B; Villard PH; Point H; Catalin J; Durand A
    Anesth Analg; 1995 Oct; 81(4):855-61. PubMed ID: 7574023
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro glucuronidation of Armillarisin A: UDP-glucuronosyltransferase 1A9 acts as a major contributor and significant species differences.
    Sun D; Zhu L; Xiao L; Xia Y; Ge G; Cao Y; Wu Y; Yin J; Yang L
    Xenobiotica; 2014 Nov; 44(11):988-95. PubMed ID: 24916899
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Raloxifene glucuronidation in human intestine, kidney, and liver microsomes and in human liver microsomes genotyped for the UGT1A1*28 polymorphism.
    Trdan Lusin T; Trontelj J; Mrhar A
    Drug Metab Dispos; 2011 Dec; 39(12):2347-54. PubMed ID: 21937736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.